Study details
Enrolling now
Neuromodulation and Cognitive Training for Substance Use Disorders
University of Minnesota
NCT IDNCT04426214ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 5.1 years
Ages
18–65
Locations
1 site in MN
What this study is about
This trial is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage brain biomarkers of relapse vulnerability. The goal is to improve cognition and treatment outcomes in people with alcohol or stimulant use disorders.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Cognitive Training
- 2.Use tDCS
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Devices
therapeutic
Body systems
Psychiatry / Mental Health